Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
about
Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog.Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches.Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.Costs and consequences of immunosuppressive therapy in children with aplastic anemia.The progression risk factors of children with transfusion-independent non-severe aplastic anemia.Successful obstetric and hematologic outcome of aplastic anemia in a pregnant Jehovah's Witness.Diagnosis and Treatment of Aplastic Anemia.Paediatric amendment to adult BSH Guidelines for aplastic anaemia.Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.Danazol as first-line therapy for aplastic anemia.Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation.
P2860
Q33419679-35E31809-592E-4B0E-8E86-CB145A0B263EQ37393836-35770A36-15D6-47AC-B54A-08279EB2FD87Q37884078-1D39F2CF-5441-4572-9152-2FDD3BD229ABQ38740791-EEDE0777-5506-44F6-B2C4-D306372473B4Q41671706-0084D9D1-F187-4FA4-A025-DE1EA1FCD84EQ42743020-B35E9A9C-F361-429C-9B63-8FCAD79CFF14Q43681127-31D3B40D-4A2C-4B84-8681-A94767667076Q47706930-A88BDEE2-C9BD-4383-B956-8DD3D5647F68Q47836932-07EE441C-D786-48AE-B319-2497E8B94DC0Q48333946-5892603F-2C94-49CE-A876-565A9AFE6E85Q49692611-EC9240CD-F4B4-450E-BA70-9D0780D5E05CQ51003191-737B6C98-1F06-4B90-8446-799DFE3B0921Q53271319-4EF3FD10-52D3-497D-A01F-552E6613E4FCQ54519224-939DE976-5378-43C5-A81D-D5AF6295CF98
P2860
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@en
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@nl
type
label
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@en
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@nl
prefLabel
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@en
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@nl
P2093
P356
P1476
Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
@en
P2093
Hirohito Yamazaki
Mitsuhiro Omine
Shinji Nakao
Tatsuya Chuhjo
P304
P356
10.1002/AJH.21118
P577
2008-05-01T00:00:00Z